The humble aspirin tablet has once again been shown to lower the likelihood of developing cancer. A number of studies have hinted that aspirin may have anti-cancer potential, but the benefit was not the same in every study.
In a new analysis, health records of more than 100,000 American adults were examined for ten years. When first recruited to the Cancer Prevention Study II Nutrition Cohort, these seniors filled out detailed questionnaires that included their history of aspirin use. They also responded to questions every two years throughout the study. The scientists found that those who took aspirin daily lowered their risk of digestive tract cancers by 40 percent. Doctors caution, however, that taking aspirin can increase the possibility of dangerous gastrointestinal bleeding and that it should not be undertaken without medical supervision.
[Journal of the National Cancer Institute, online, Aug. 10, 2012]
Redirected 4/28.16 to https://www.peoplespharmacy.com/2016/04/28/how-to-reduce-your-risk-of-bile-duct-cancer/